PCR203 The Clinical and Financial Impact of GLP-1 Receptor Agonist and SGLT-2 Inhibitor Use in Type 2 Diabetes Management of Blue Cross and Blue Shield of Louisiana Members
Jun 1, 2023, 00:00
10.1016/j.jval.2023.03.2382
https://www.valueinhealthjournal.com/article/S1098-3015(23)02482-8/fulltext
Title :
PCR203 The Clinical and Financial Impact of GLP-1 Receptor Agonist and SGLT-2 Inhibitor Use in Type 2 Diabetes Management of Blue Cross and Blue Shield of Louisiana Members
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(23)02482-8&doi=10.1016/j.jval.2023.03.2382
First page :
Section Title :
Open access? :
No
Section Order :
11300